Candida auris: Using Public Health Messaging to Address Prevention
March 31st 2023Despite the recent CDC warning and frightening media coverage, understanding which patients are at a higher risk of Candida auris is important too. The lead author of the recent CDC's study spoke to ICT's sister brand for further insights on the threat.
Respiratory Spread and the Flawed Concept of Immunological Debt: A New Understanding
November 8th 2022CDC discusses potential proposals to redefine spread and to produce uniform guidelines across different types of facilities because public health interventions do not cause immunological debt but instead may prevent immunocompromising infections.
Pfizer Announces Encouraging Data on RSV Vaccine for Pregnant Persons
November 1st 2022Respiratory syncytial virus (RSV) can be deadly for newborns and young infants. The newest information from Pfizer about its RSCpreF investigational vaccine is promising for new mothers and infants through the first 90 days of life.
Is the Current Bivalent Booster the Correct One? Studies Suggest it Isn't
November 1st 2022Despite study results that the univalent BA.5 booster produced much higher increase in antibodies, why was the hybrid bivalent Ancestral/BA.5 booster with a significantly lower increase chosen to be distributed, and how does this put the population at risk?